×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Hematology
5119
Global Medical University
4538
Allergy
1700
Anatomy & Morphology
1452
Andrology
414
Anesthesia & Intensive Care
1078
Anesthesiology
4982
Audiology & Speech-Language Pathology
311
Behavioral Sciences
100
Biochemical Research Methods
6154
Biochemistry & Molecular Biology
27279
Biodiversity Conservation
255
Biology
7468
Biophysics
7334
Biotechnology & Applied Microbiology
7470
Cardiac & Cardiovascular Systems
28711
Cardiovascular & Respiratory Systems
1295
Cell & Tissue Engineering
596
Cell Biology
10183
Chemistry, Analytical
3943
Chemistry, Applied
10441
Chemistry, Medicinal
8031
Chemistry, Multidisciplinary
17594
Clinical Immunology & Infectious Disease
397
Clinical Medicine
8395
Clinical Neurology
15078
Clinical Psychology & Psychiatry
1151
Critical Care Medicine
2865
Dentistry, Oral Surgery & Medicine
11853
Dermatology
7388
Developmental Biology
6544
Ecology
627
Education, Scientific Disciplines
1712
Emergency Medicine
3607
Endocrinology, Metabolism & Nutrition
21673
Engineering, Biomedical
3288
Entomology
392
Environmental Medicine & Public Health
4301
Evolutionary Biology
232
Gastroenterology & Hepatology
10835
General & Internal Medicine
6445
Genetics & Heredity
13615
Geriatrics & Gerontology
4644
Gerontology
314
Health Care Sciences & Services
14294
Health Policy & Services
542
Immunology
23010
Infectious Diseases
12703
Integrative & Complementary Medicine
2481
Medical Ethics
1029
Medical Informatics
1879
Medical Laboratory Technology
433
Medicine, General & Internal
41848
Medicine, Legal
434
Medicine, Research & Experimental
16163
Microbiology
21165
Mycology
0
Nanoscience & Nanotechnology
4608
Neuroimaging
1134
Neurology
4008
Neurosciences
35915
Nursing
8517
Nutrition & Dietetics
7465
Obstetrics & Gynecology
7491
Oncology
48380
Ophthalmology
8694
Optics
3624
Orthopedics
10349
Orthopedics, Rehabilitation & Sports Medicine
1579
Otolaryngology
1406
Otorhinolaryngology
4486
Parasitology
946
Pathology
4481
Pediatrics
19600
Peripheral Vascular Disease
4219
Pharmacology & Pharmacy
31010
Pharmacology/Toxicology
11323
Physiology
8462
Polymer Science
496
Primary Health Care
738
Psychiatry
17344
Psychology
4647
Psychology, Applied
74
Psychology, Biological
296
Psychology, Clinical
711
Psychology, Developmental
204
Psychology, Educational
116
Psychology, Experimental
103
Psychology, Mathematical
0
Psychology, Multidisciplinary
1473
Psychology, Psychoanalysis
41
Psychology, Social
101
Public Health & Health Care Science
2073
Public, Environmental & Occupational Health
25455
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
11034
Radiology, Nuclear Medicine & Medical Imaging
7267
Rehabilitation
2798
Remote Sensing
0
Reproductive Biology
2518
Reproductive Medicine
1059
Research/Laboratory Medicine & Medical Technology
3586
Respiratory System
6480
Rheumatology
5245
Social Sciences, Biomedical
1110
Substance Abuse
2490
Surgery
30640
Toxicology
3980
Transplantation
878
Tropical Medicine
314
Urology & Nephrology
11746
Veterinary Sciences
35
Virology
2236
Zoology
0
渠道
BLOOD CANCER JOURNAL
410
Hematology\Oncology
3
Medrxiv - Hematology
150
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
465
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
121
BLOOD COAGULATION & FIBRINOLYSIS
60
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
40
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
197
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
139
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
366
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
92
INTERNATIONAL JOURNAL OF HEMATOLOGY
504
JOURNAL OF HEMATOPATHOLOGY
106
SCI时时刷
search
全部
推荐
+
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents
Competing interests DH: None. SL: None. SAW: None. MYK: reports research c...
Blood Cancer Journal
comment
0
thumb_up
0
The expanding CML treatment landscape: an introspective commentary
The article by Abdelmagid and co-authors on real-world experience with ponatinib that accompanies this ed...
Blood Cancer Journal
comment
0
thumb_up
0
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors
FLT3 is the most frequently mutated gene in acute myeloid leukemia (AML), with FLT3 internal tandem duplication (ITD) muta...
Blood Cancer Journal
comment
0
thumb_up
0
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma
Biallelic TP53 inactivation is the most important high-risk factor associated with poor survival in multiple myeloma. Clas...
Blood Cancer Journal
comment
0
thumb_up
0
Zanubrutinib: past, present, and future
In recent years, Bruton tyrosine kinase (BTK) inhibitors have provided significant advances in the treatment of patients w...
Blood Cancer Journal
comment
0
thumb_up
0
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib
Variability in the molecular response to frontline tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia may...
Blood Cancer Journal
comment
0
thumb_up
0
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
Acute myeloid leukemia (AML) can be classified into multiple genetic subtypes based on recurrent pathogen...
Blood Cancer Journal
comment
0
thumb_up
0
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis
Rituximab-based chemo-immunotherapy is currently the standard first-line treatment for Waldenstrom macroglobulinaemia (WM)...
Blood Cancer Journal
comment
0
thumb_up
0
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
The deregulation of BCL2 family proteins plays a crucial role in leukemia development. Therefore, pharmacological inhibiti...
Blood Cancer Journal
comment
0
thumb_up
0
Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement
Langerhans cell histiocytosis (LCH) is a rare, heterogeneous histiocytic disease derived from the misguid...
Blood Cancer Journal
comment
0
thumb_up
0
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
Prolonged viral shedding (PVS) results from a failure of viral eradication. Before the emergence of SARS-...
Blood Cancer Journal
comment
0
thumb_up
0
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
Testing for measurable residual disease (MRD) in persons with plasma cell myeloma (PCM) after therapy cor...
Blood Cancer Journal
comment
0
thumb_up
0
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
Multiple myeloma (MM) is a rarely curable plasma cell malignancy of the bone marrow (BM) that provides a ...
Blood Cancer Journal
comment
0
thumb_up
0
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Autologous stem cell transplant (ASCT) remains an important option for eligible multiple myeloma (MM) patients as part of ...
Blood Cancer Journal
comment
0
thumb_up
0
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Molecular techniques are the gold standard method for the diagnosis of AML with mutated nucleophosmin gen...
Blood Cancer Journal
comment
0
thumb_up
0
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
Gemtuzumab ozogamicin (GO) is a CD33-directed antibody-drug conjugate approved for the treatment of newly diagnosed (ND) a...
Blood Cancer Journal
comment
0
thumb_up
0
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics
Histological transformation of marginal zone lymphoma (tMZL) into diffuse large B-cell lymphoma is associated with poor ou...
Blood Cancer Journal
comment
0
thumb_up
0
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, CanadaArleigh McCurdy & Alissa VisramJuravinski C...
Blood Cancer Journal
comment
0
thumb_up
0
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous l...
Blood Cancer Journal
comment
0
thumb_up
0
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity
PET/CT is used to evaluate relapsed/refractory non-Hodgkin lymphoma (NHL) prior to chimeric antigen receptor T-cell (CAR-T...
Blood Cancer Journal
comment
0
thumb_up
0
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many ...
Blood Cancer Journal
comment
0
thumb_up
0
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
The real-world patient-level data were derived from two prospective cohort studies. The first SMC-LCS (2008–2011, NCT#0082...
Blood Cancer Journal
comment
0
thumb_up
0
The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain
MYD88 is the key signaling adaptor-protein for Toll-like and interleukin-1 receptors. A somatic L265P mutation within the ...
Blood Cancer Journal
comment
0
thumb_up
0
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma
T-lymphocytes are prevalent in the tumor microenvironment of follicular lymphoma (FL). However, the phenotype of T-cells m...
Blood Cancer Journal
comment
0
thumb_up
0
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
We surveyed the performance of ponatinib, as salvage therapy, in a real-world setting of chronic phase chronic myeloid leu...
Blood Cancer Journal
comment
0
thumb_up
0
Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells
Multiple hematological malignancies can occur simultaneously or sequentially in a single patient. They ar...
Blood Cancer Journal
comment
0
thumb_up
0
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort
The continuous treatment model of Bruton tyrosine kinase inhibitors (BTKi) in chronic lymphocytic leukemi...
Blood Cancer Journal
comment
0
thumb_up
0
Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare neoplasm derived from plasmacytoid dendrit...
Blood Cancer Journal
comment
0
thumb_up
0
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimiza...
Blood Cancer Journal
comment
0
thumb_up
0
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy
Most patients with multiple myeloma experience disease relapse after treatment with a B-cell maturation antigen-targeted t...
Blood Cancer Journal
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin